A Simple Nonviral Method to Generate Human Induced Pluripotent Stem Cells Using SMAR DNA Vectors.

Autor: Hartley, Anna, Burger, Luisa, Wincek, Cornelia L., Dons, Lieke, Li, Tracy, Grewenig, Annabel, Taşgın, Toros, Urban, Manuela, Roig-Merino, Alicia, Ghazvini, Mehrnaz, Harbottle, Richard P.

Publikováno v: Genes; May2024, Vol. 15 Issue 5, p575, 17p

Oncolytic H-1 parvovirus binds to sialic acid on laminins for cell attachment and entry

Autor: Kulkarni, Amit, Ferreira, Tiago, Bretscher, Clemens, Grewenig, Annabel, El-Andaloussi, Nazim, Bonifati, Serena, Marttila, Tiina, Palissot, Valèrie, Hossain, Jubayer A., Azuaje, Francisco, Miletic, Hrvoje, Ystaas, Lars Andreas Rømo, Golebiewska, Anna, Niclou, Simone Pierrette, Roeth, Ralf, Niesler, Beate, Weiss, Amélie, Brino, Laurent, Marchini, Antonio

Externí odkaz: https://hdl.handle.net/11250/2834774

H-1 Parvovirus-Associated Replication Bodies: a Distinct Virus-Induced Nuclear Structure

Autor: Cziepluch, Celina, Lampel, Stefan, Grewenig, Annabel, Grund, Christine, Lichter, Peter, Rommelaere, Jean

Publikováno v: The Journal of Virology; May 2000, Vol. 74 Issue: 10 p4807-4815, 9p

Oncolytic H-1 parvovirus binds to sialic acid on laminins for cell attachment and entry.

Autor: Kulkarni A; Laboratory of Oncolytic Virus Immuno-Therapeutics, German Cancer Research Center, Heidelberg, Germany.; Laboratory of Oncolytic Virus Immuno-Therapeutics, Luxembourg Institute of Health, Luxembourg, Luxembourg., Ferreira T; Laboratory of Oncolytic Virus Immuno-Therapeutics, German Cancer Research Center, Heidelberg, Germany., Bretscher C; Laboratory of Oncolytic Virus Immuno-Therapeutics, German Cancer Research Center, Heidelberg, Germany., Grewenig A; Laboratory of Oncolytic Virus Immuno-Therapeutics, German Cancer Research Center, Heidelberg, Germany., El-Andaloussi N; Laboratory of Oncolytic Virus Immuno-Therapeutics, German Cancer Research Center, Heidelberg, Germany.; Lonza Cologne GmbH, Köln, Germany., Bonifati S; Laboratory of Oncolytic Virus Immuno-Therapeutics, German Cancer Research Center, Heidelberg, Germany.; Center for Retrovirus Research, Department of Veterinary Biosciences, The Ohio State University, Columbus, OH, USA., Marttila T; Laboratory of Oncolytic Virus Immuno-Therapeutics, German Cancer Research Center, Heidelberg, Germany.; Laboratory of Oncolytic Virus Immuno-Therapeutics, Luxembourg Institute of Health, Luxembourg, Luxembourg., Palissot V; Laboratory of Oncolytic Virus Immuno-Therapeutics, Luxembourg Institute of Health, Luxembourg, Luxembourg., Hossain JA; Laboratory of Oncolytic Virus Immuno-Therapeutics, Luxembourg Institute of Health, Luxembourg, Luxembourg.; Department of Biomedicine, University of Bergen, Bergen, Norway.; Department of Pathology, Haukeland University Hospital, Bergen, Norway., Azuaje F; Quantitative Biology Unit, Luxembourg Institute of Health, Luxembourg, Luxembourg.; Genomics England, London, United Kingdom., Miletic H; Department of Biomedicine, University of Bergen, Bergen, Norway.; Department of Pathology, Haukeland University Hospital, Bergen, Norway., Ystaas LAR; Department of Biomedicine, University of Bergen, Bergen, Norway., Golebiewska A; NorLux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg, Luxembourg., Niclou SP; NorLux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg, Luxembourg., Roeth R; nCounter Core Facility, Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany.; Department of Human Molecular Genetics, University of Heidelberg, Heidelberg, Germany., Niesler B; nCounter Core Facility, Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany.; Department of Human Molecular Genetics, University of Heidelberg, Heidelberg, Germany., Weiss A; Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Illkirch, France., Brino L; Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Illkirch, France., Marchini A; Laboratory of Oncolytic Virus Immuno-Therapeutics, German Cancer Research Center, Heidelberg, Germany. antonio.marchini@lih.lu.; Laboratory of Oncolytic Virus Immuno-Therapeutics, Luxembourg Institute of Health, Luxembourg, Luxembourg. antonio.marchini@lih.lu.

Publikováno v: Nature communications [Nat Commun] 2021 Jun 22; Vol. 12 (1), pp. 3834. Date of Electronic Publication: 2021 Jun 22.